🇺🇸 FDA
Patent

US 10787446

Therapeutic compounds and methods of use thereof

granted A61PA61P17/04

Quick answer

US patent 10787446 (Therapeutic compounds and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P17/04